InVitro International

Total Valuation

InVitro International carries a market capitalization of 1.34M, placing it among publicly traded companies globally. Its enterprise value stands at 913,495.71, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

InVitro International currently has 22.26M shares outstanding.

Valuation Ratios

InVitro International trades at a trailing price-to-earnings ratio of 29.98. The price-to-sales ratio is 2.45, and the price-to-book ratio stands at 1.12.

Enterprise Valuation

On an enterprise value basis, InVitro International trades at an EV/EBITDA multiple of 19.80 and an EV/FCF ratio of 176.86. The EV/Sales ratio of 1.18 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.60 provides insight into valuation relative to core operating earnings.

Financial Position

InVitro International maintains a current ratio of 11.56, meaning it holds 11.6x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

InVitro International posts a return on equity of 3.75 and a return on invested capital of 1.70.

Taxes

Over the trailing twelve months, InVitro International has paid 2,589.00 in income taxes, reflecting an effective tax rate of 3.94.

Stock Price Statistics

InVitro International's stock has declined approximately -22.07792% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.08.

Income Statement

Over the trailing twelve months, InVitro International generated 771,057.00 in revenue and converted that into 63,057.00 in net income, yielding earnings per share of 0.00. EBITDA reached 46,141.00, while operating income came in at 34,337.00.

Balance Sheet

InVitro International holds 1.23M in cash and equivalents against 240,298.00 in total debt, resulting in a net debt position of -1.23M. Total book value stands at 1.70M, with working capital of 1.38M providing operational flexibility.

Cash Flow

InVitro International produced 4,068.00 in operating cash flow over the past twelve months. After subtracting -1,097.00 in capital expenditures, free cash flow totaled 2,971.00 - equivalent to 0.00 per share.

Margins

InVitro International operates with a gross margin of 81.88, reflecting its pricing power and cost economics. The operating margin of 4.45 and net profit margin of 8.18 provide insight into operational efficiency.

Dividends & Yields

Scores

InVitro International posts an Altman Z-Score of 5.74, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.